These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8463250)

  • 1. Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase.
    Hogg PJ; Owensby DA; Mosher DF; Misenheimer TM; Chesterman CN
    J Biol Chem; 1993 Apr; 268(10):7139-46. PubMed ID: 8463250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats.
    Hogg PJ; Owensby DA; Chesterman CN
    J Biol Chem; 1993 Oct; 268(29):21811-8. PubMed ID: 8408036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase.
    Hogg PJ; Jiménez BM; Chesterman CN
    Biochemistry; 1994 May; 33(21):6531-7. PubMed ID: 8204588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin is a slow tight-binding inhibitor of plasmin.
    Hogg PJ; Stenflo J; Mosher DF
    Biochemistry; 1992 Jan; 31(1):265-9. PubMed ID: 1531022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple domains are involved in the interaction of endothelial cell thrombospondin with fibronectin.
    Dardik R; Lahav J
    Eur J Biochem; 1989 Nov; 185(3):581-8. PubMed ID: 2512126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK; Yoo JK; Webb DJ; Gonias SL
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible inhibition of neutrophil elastase by thiol-modified alpha-1 protease inhibitor.
    Tyagi SC
    J Biol Chem; 1991 Mar; 266(8):5279-85. PubMed ID: 2002060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS; Zeng Z; Walz DA
    Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin.
    Ying QL; Simon SR
    Biochemistry; 1993 Feb; 32(7):1866-74. PubMed ID: 8439544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K; Léránt I; Tenekejiev K; Machovich R
    J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion.
    Ostergaard E; Flodgaard H
    J Leukoc Biol; 1992 Apr; 51(4):316-23. PubMed ID: 1564396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced conformational change and activation of mucus proteinase inhibitor.
    Faller B; Mely Y; Gerard D; Bieth JG
    Biochemistry; 1992 Sep; 31(35):8285-90. PubMed ID: 1525165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils.
    Padrines M; Schneider-Pozzer M; Bieth JG
    Am Rev Respir Dis; 1989 Mar; 139(3):783-90. PubMed ID: 2784294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin gelatin-binding activity: effects of platelet thrombospondin, serum, and plasma.
    Gelder FB; Brown ST
    J Lab Clin Med; 1987 Nov; 110(5):548-57. PubMed ID: 3312442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
    Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
    Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin.
    Sipes JM; Guo N; Nègre E; Vogel T; Krutzsch HC; Roberts DD
    J Cell Biol; 1993 Apr; 121(2):469-77. PubMed ID: 8468356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of low molecular mass heparin on the kinetics of neutrophil elastase inhibition by mucus proteinase inhibitor.
    Cadène M; Boudier C; de Marcillac GD; Bieth JG
    J Biol Chem; 1995 Jun; 270(22):13204-9. PubMed ID: 7768918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin.
    Grinnell F; Zhu M
    J Invest Dermatol; 1994 Aug; 103(2):155-61. PubMed ID: 8040604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding.
    Lahav J; Lawler J; Gimbrone MA
    Eur J Biochem; 1984 Nov; 145(1):151-6. PubMed ID: 6489349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.